Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. senior Avg
|
New words:
allegedly, arbitration, authoritative, bearing, bolster, CA, Circuit, comment, compensatory, conspiracy, County, CVI, deadline, disappointing, enjoin, enrichment, estate, Faulkner, Hedging, icare, Index, interference, latory, Legacy, Med, Mediation, nominal, noncash, nonstatutory, pre, reclassification, reclassified, regu, rendering, replevin, restraining, retroactively, ROU, salvage, stayed, superseding, Turbare, unjust
Removed:
Allocate, assessed, award, California, confirmation, consisted, decision, exceeded, excluded, expiring, fall, free, identification, ineligible, letter, lieu, obsolescence, OTC, permanent, principle, qualifying, Recognize, recovery, registering, renew, resold, ripple, sentence, settled, settlement, stating, transferring, underwritten, world
Financial report summary
?Management Discussion
- Our consolidated results of operations are presented for the year ending December 31, 2022 and December 31, 2021. The financial results (revenues and expenses) relating to the USC business are reflected in Note 4, Discontinued Operations and Assets Held for Sale, of the notes to the consolidated financial statements appearing elsewhere in this Report. The discussion below, and the revenues and expenses discussed below, are based on and relate to the continuing operations of the company, which we sometimes refer to as our drug development and commercialization business, unless otherwise noted.